Stockscreener 앱 받기
12.22
2.00%
-0.25
시간 외 거래:
11.90
-0.32
-2.62%
전일 마감가:
$12.47
열려 있는:
$12.41
하루 거래량:
50,553
Relative Volume:
0.57
시가총액:
$103.37M
수익:
-
순이익/손실:
$-6.42M
주가수익비율:
-1.2809
EPS:
-9.54
순현금흐름:
$-7.45M
1주 성능:
-9.35%
1개월 성능:
-14.84%
6개월 성능:
-49.21%
1년 성능:
+11.80%
1일 변동 폭
$11.95
$12.71
1주일 범위
$11.95
$14.62
52주 변동 폭
$5.85
$26.38
Cervomed Inc Stock (CRVO) Company Profile
명칭
Cervomed Inc
전화
(617) 744-4400
주소
20 PARK PLAZA, BOSTON
Cervomed Inc Stock (CRVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-11-17 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2018-03-21 | 개시 | H.C. Wainwright | Buy |
Cervomed Inc 주식(CRVO)의 최신 뉴스
CervoMed Announces Key Takeaways from Oral Presentations at - GlobeNewswire
CervoMed Announces Key Takeaways from Oral Presentations at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD) - StockTitan
CervoMed Inc. (NASDAQ:CRVO) Short Interest Up 7.6% in October - MarketBeat
CervoMed (NASDAQ:CRVO) Shares Down 3.1% – Time to Sell? - Defense World
CervoMed (NASDAQ:CRVO) Stock Price Down 3.1%What's Next? - MarketBeat
CervoMed to Present Phase 2b Trial Results - TipRanks
CervoMed to Deliver Oral Presentation at the 8th International Lewy Body Dementia Conference - GlobeNewswire
Insiders of CervoMed Inc. (NASDAQ:CRVO) were rewarded after last week’s 11% gain - Simply Wall St
CRVOCervoMed Inc. Latest Stock News & Market Updates - StockTitan
CervoMed Announces Last Patient Last Visit in Phase 2b - GlobeNewswire
CervoMed Announces Last Patient Last Visit in Phase 2b RewinD-LB Trial of Neflamapimod for the Treatment of Early-Stage Dementia with Lewy Bodies (DLB) - StockTitan
CervoMed Ends $20 Million Stock Sales Agreement with BTIG - Yahoo Finance
CervoMed ends sales agreement with BTIG By Investing.com - Investing.com South Africa
CervoMed ends sales agreement with BTIG - Investing.com India
CervoMed to Participate in 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewswire
CervoMed Inc. (NASDAQ:CRVO) Short Interest Update - MarketBeat
CervoMed to Deliver Late-Breaking Oral Presentations at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD) - The Manila Times
CervoMed to present on neflamapimod as DLB treatment at CTAD - TipRanks
CervoMed to Deliver Late-Breaking Oral Presentations at the - GlobeNewswire
Armistice Capital LLC Sells 94,363 Shares of CervoMed Inc. (NASDAQ:CRVO) - MarketBeat
There is no way Cerence Inc (CRNC) can keep these numbers up - SETE News
Credo Technology Group (NASDAQ:CRDO) Trading Up 3% - MarketBeat
Certara Inc (CERT)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Closing Figures Unveiled: Cemtrex Inc. (CETX) Drop -3.49, Closes at 0.14 - The Dwinnex
Examining Certara Inc (CERT) more closely is necessary - US Post News
Cerence Inc. (CRNC)’s $40 Million Revenue Guidance Signals Trouble for Investors - Insider Monkey
(CRVO) Technical Pivots with Risk Controls - Stock Traders Daily
CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236 - StockTitan
Holdings of CERo Therapeutics Holdings Inc. (CERO) are aligned with the stars - SETE News
CERo Therapeutics Holdings Inc. (CERO)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
With 65% ownership, Cerus Corporation (NASDAQ:CERS) boasts of strong institutional backing - Yahoo Finance
Renaissance Technologies LLC Has $8.34 Million Position in Commercial Vehicle Group, Inc. (NASDAQ:CVGI) - Defense World
Croda International (OTCMKTS:COIHD) Sets New 52-Week Low at $26.75 - Defense World
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid - Business Wire
A significant driver of top-line growth: Certara Inc (CERT) - SETE News
Cerence Inc’s latest rating changes from various analysts - Knox Daily
Closing Figures Unveiled: Corvus Pharmaceuticals Inc (CRVS) Drop -7.95, Closes at 5.44 - The Dwinnex
Perhaps timely catching Cerus Corp. (CERS) would be a good idea - SETE News
Is it possible to buy Cerence Inc(CRNC) shares at a good price now? - US Post News
Hood River Capital Management LLC Acquires 1,170,060 Shares of Cerus Co. (NASDAQ:CERS) - Defense World
What Makes Criteo (CRTO) an Attractive Pick? - Yahoo Finance
Credo Technology Group Holding Ltd (CRDO) requires closer examination - US Post News
Investing in Cerus Corp. (CERS) Is Getting More Attractive - Knox Daily
‘An Amazing Physical Force’: Richard Spooner Remembers Cristallo - The Chronicle of the Horse
The Potential Rise in the Price of Credo Technology Group Holding Ltd (CRDO) following insiders activity - Knox Daily
Cercle raises USD 6M in seed funding - Medical Buyer
Corvus Pharmaceuticals Inc [CRVS] Stock bought by Insider Jones William Benton for $34624.0 - Knox Daily
Ceva Inc. (CEVA) looking to reclaim success with recent performance - SETE News
Top investors say Criteo S.A ADR (CRTO) ticks everything they need - SETE News
Stock Performance Spotlight: Cerus Corp. (CERS) Ends the Day at 1.80, Down by -1.64 - The Dwinnex
Examining CERo Therapeutics Holdings Inc. (CERO) stock is warranted - US Post News
Cervomed Inc (CRVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):